RVU (RVU) News
Track canonical SquawkNews coverage tagged to RVU, RVU. This hub brings together deduplicated headlines about nasdaqgs, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Ryvu Therapeutics Q2 net loss 13.1 million zlotys
Ryvu Therapeutics reported a Q2 net loss of 13.1 million zlotys.
EQUITY | Sep 17, 2026, 05:01 AM UTC
L
Ryvu Therapeutics “Dualis” project recommended for 22.2 mln zloty subsidy
Ryvu Therapeutics’ “Dualis” project was recommended for a 22.2 million zloty subsidy.
EQUITY | Sep 07, 2026, 04:01 PM UTC